Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-06

FDA Approved: CLOPIDOGREL — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Torrent Pharmaceuticals Limited's supplemental application for clopidogrel under ANDA090844, finalizing an approval for its generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clopidogrel (generic) (clopidogrel)

Snippet

SUPPL AP for CLOPIDOGREL (CLOPIDOGREL)